Latest FDA Stories
This webinar will explore modern technologies of facility redevelopment that can extend the life of a facility by 10 -20 years.
The Software and Cybersecurity Risk Management for Medical Device conference — chaired by internationally renowned expert Fubin Wu — has been specifically designed to provide attendees with
In two days, two of the industry's top inspectional readiness professionals will lead attendees through all aspects of the inspections process.
- Jadenu (deferasirox), a new formulation of Exjade (deferasirox), is the only once-daily oral tablet for iron chelation EAST HANOVER, N.J., March 30, 2015 /PRNewswire/ -- Novartis announced
Application Designed to Support Conversion of Accelerated to Full FDA Approval THOUSAND OAKS, Calif., March 30, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the U.S.
Efficacy and Safety of Long-term, Continuous Anti-VEGF will be Assessed in Phase 2 Study CUMBERLAND, R.I., March 30, 2015 /PRNewswire/ -- Neurotech Pharmaceuticals, Inc.
Transplant surgeon of the stars, Dr.
The publication of the analysis echoes recent FDA concerns that prescription low testosterone treatments are being used extensively to relieve low hormone levels normally associated with male
Coalition highlights momentum behind campaign for approval of first-ever drug for women's sexual dysfunction, launches new website for supporters to contact their elected representatives
With FDA's Approval of the First Biosimilar in the U.S., Groups Urge OMB to Work with FDA to Finalize Critical Naming Policy Supporting Patient Safety WASHINGTON, March 26, 2015 /PRNewswire-USNewswire/
- Large; stout; burly.